HAP Trading »

Summit Therapeutics shares owned by HAP Trading

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by HAP Trading from 13F filings

Historical chart of HAP Trading investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by HAP Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by HAP Trading

Quarter filed Position value Share count Share price at filing
2024-12-31 $432 45k 0.01

More positions owned by HAP Trading

Meta Platforms Cl A (META)
Coinbase Global Com Cl A (COIN)
Applovin Corp Com Cl A Call Option (APP)
Tesla Motors (TSLA)
Amazon (AMZN)
Ishares Msci Cda Etf (EWC)
Advanced Micro Devices (AMD)
Broadcom Call Option (AVGO)
Hldgs (UAL)
NVIDIA Corporation Call Option (NVDA)
Palantir Technologies Cl A (PLTR)
Ge Aerospace Com New (GE)
Vaneck Etf Trust Semiconductr Etf (SMH)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Netflix Call Option (NFLX)

View all positions for HAP Trading

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
FMR
BlackRock
State Street Corporation
Geode Capital Management
Susquehanna International
Pictet Asset Management Holding SA
Citadel Advisors
UBS Group
Apeiron Capital
Nomura Holdings
Standard Life Aberdeen
Squarepoint Ops
Sofinnova Ventures

View all funds holding Summit Therapeutics